Page 1448 - Williams Hematology ( PDFDrive )

1422 Part X: Malignant Myeloid Diseases Chapter 88: Acute Myelogenous Leukemia 1423

487. Huang W, Sun GL, Li XS, et al: Acute promyelocytic leukemia: Clinical relevance of 521. Santiago-Schwarz F, Coppock DL, Hindenburg A, Kern J: Identification of a malig-
two major PML-RAR alpha isoforms and detection of minimal residual disease by nant counterpart of the monocytic-dendritic cell progenitor in acute myeloid leuke-
retrotranscriptase/polymerase chain reaction to predict relapse. Blood 82:1264, 1993. mia. Blood 84:3054, 1994.
488. Rego EM, Pandolfi PP: Analysis of molecular genetics of acute promyelocytic leuke- 522. Pileri SA, Grogan TM, Harris NL, et al: Tumors of histiocytes and accessory dendritic
mia in mouse models. Semin Hematol 38:54, 2001. cells: An immunohistochemical approach to classification from the International
489. Dombret H, Scrobohaci ML, Ghorra P, et al: Coagulation disorder associated with acute Lymphoma Study Group based on 61 cases. Histopathology 41:1, 2002.
promyelocytic leukemia: Correct effect of all-trans retinoic acid. Leukemia 7:2, 1993. 523. Elghetany MT: True histiocytic lymphoma: Is it an entity? Leukemia 11:762, 1997.
490. Tallman MS, Kwaan HC: Reassessing the hemostatic disorder associated with acute 524. Esteve J, Rozman M, Campo E, et al: Leukemia after true histiocytic lymphoma:
promyelocytic leukemia. Blood 79:543, 1992. Another type of acute monocytic leukemia with histiocytic differentiation (AML-
491. Barbui T, Finazzi G, Falanga A: The impact of all-trans retinoic acid on the coagulop- M5c). Leukemia 9:1389, 1995.
athy of acute promyelocytic leukemia. Blood 91:3093, 1998. 525. Tallman MS, Kim HT, Paietta E, et al: Acute monocytic leukemia (French-American-
492. Menell JS, Cesarman GM, Jacovina AT, et al: Annexin II and bleeding in acute promy- British classification M5) does not have a worse prognosis than other subtypes of acute
elocytic leukemia. N Engl J Med 340:994, 1999. myeloid leukemia: Report from the Eastern Cooperative Group. J Clin Oncol 22:1276,
493. Avvisati G, Ten Cate JW, Büller H, Mandelli F: Tranexamic acid for control of haem- 2004.
orrhage in patients with acute promyelocyte leukaemia. Lancet 2:122, 1989. 526. Lewis SM, Szur L: Malignant myelosclerosis. Br Med J 2:472, 1963.
494. Tallman MS, Abutalib SA, Altman JK: The double hazard of thrombophilia and bleed- 527. Bergsman KL, VanSlyck EJ: Acute myelofibrosis. Ann Intern Med 74:232, 1971.
ing in acute promyelocytic leukemia. Semin Thromb Hemost 33:330, 2007. 528. Huang MJ, Li CY, Nichols WL, et al: Acute leukemia with megakaryocytic differenti-
495. Fenaux P, Tertian G, Castaigne S, et al: A randomized trial of amsacrine and rubida- ation. A study of twelve cases identified immunocytochemically. Blood 64:427, 1984.
zone on 39 patients with acute promyelocytic leukemia. J Clin Oncol 9:1556, 1991. 529. Gassman W, Löffler H: Acute megakaryoblastic leukemia. Leuk Lymphoma 18:69,
496. Craddock CG, Crandall BF, Como R: Restoration of effective hemopoiesis preceding 1995.
suppression of leukemia clone in myeloblastic leukemia. Am J Med 59:737, 1975. 530. Cripe LD, Hromas R: Malignant disorders of megakaryocytes. Semin Hematol 35:200,
497. Amato R, Kantarjian H, Walter R, Keating M: Rebound peripheral blastosis with sub- 1998.
sequent remission during induction in a patient with acute promyelocytic leukemia. 531. Paredes-Aguilera R, Romero-Guzman L, Lopez-Santiago N, Trejo RA: Biological,
Cancer 61:650, 1988. clinical, and hematological features of acute megakaryoblastic leukemia in children.
498. Stone RM, Maguire M, Goldberg MA, et al: Complete remission in acute promyelo- Am J Hematol 73:71, 2003.
cytic leukemia despite persistence of abnormal marrow promyelocytes during induc- 532. Zipursky A, Brown E, Christensen H, et al: Leukemia and/or myeloproliferative syn-
tion therapy: Experience in 34 patients. Blood 71:690, 1988. drome in neonates with Down syndrome. Semin Perinatol 21:97, 1997.
499. Breitman TR, Collins SJ, Keene BR: Terminal differentiation of human promyelocytic 533. Hussein K, Bock O, Theophile K, et al: MPL(W515L) mutation in acute megakary-
leukemic cells in primary culture in response to retinoic acid. Blood 57:1000, 1981. oblastic leukaemia. Leukemia 23:852, 2009.
500. Huang ME, Ye YC, Chen SR, et al: Use of all-trans retinoic acid in the treatment of 534. Dastugue N, Lafage-Pochitaloff M, Pages MP, et al: Cytogenetic profile of childhood
acute promyelocytic leukemia. Blood 72:567, 1988. and adult megakaryoblastic leukemia (M7): A study of the Groupe Francais de Cyto-
501. Wu X, Wang X, Qen X, et al: Four years’ experience with treatment of all-trans retinoic genetique Hematologique (GFCH). Blood 100:618, 2002.
acid in acute promyelocytic leukemia. Am J Hematol 43:183, 1993. 535. Carroll A, Civin C, Schneider N, et al: The t(1;22)(p13;q13) is non-random and
502. Lobe I, Regal-Huguet FR, Vekhoff A, et al: Myelodysplastic syndrome after acute restricted to infants with acute megakaryoblastic leukemia: A pediatric oncology group
promyelocytic leukemia: The European APLK group experience. Leukemia 17:1600, study. Blood 78:748, 1991.
2003. 536. Duchayne F, Fenneteau O, Pages MP, et al: Acute megakaryoblastic leukaemia: A
503. Garcia-Manero G, Kantarjian HM, Kornblau S, Estey E: Therapy-related myelodys- national clinical and biological study of adult and childhood cases by the Group
plastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic Francais d’Hematologie Cellulaire (GFHC). Leuk Lymphoma 44:49, 2003.
leukemia. Leukemia 17:1888, 2002. 537. Bernstein J, Dastugue N, Haas OA, et al: Nineteen cases of the t(1;22)(p13;q13) acute
504. Reschad H, Schilling-Torgau V: Ueber eine neue Leukämie durch echte Uebergangs- megakaryoblastic leukaemia of infants/children and a review of 39 cases: Report from
formen (Splenozyten-leukämie) und ihre Bedeutung für die Selbstständigkeit dieser a t(1;22) study group. Leukemia 14:216, 2000.
Zellen. Munch Med Wochenschr 60:1981, 1913. 538. Cuneo A, Mecucci C, Kerim S, et al: Multipotent stem cell involvement in megakary-
505. Straus DJ, Mertelsmann R, Koziner B, et al: The acute monocytic leukemias. Medicine oblastic leukemia: Cytologic and cytogenetic evidence in 15 patients. Blood 74:1781,
(Baltimore) 59:409, 1980. 1989.
506. Janvier M, Tobelem G, Daniel MT, et al: Acute monoblastic leukaemia. Clinical, bio- 539. Dhyashiki K, Ohyashiki JH, Hojo H, et al: Cytogenetic findings in adult acute leuke-
logical data and survival in 45 cases. Scand J Haematol 32:385, 1984. mia in myeloproliferative disorders with an involvement of megakaryocytic lineage.
507. Finaux P, Vanhaesbroucke C, Estienne MH, et al: Acute monocytic leukaemia in Cancer 65:940, 1990.
adults: Treatment and prognosis in 99 cases. Br J Haematol 75:41, 1990. 540. Kojima S, Sako M, Kato K, et al: An effective chemotherapeutic regimen for acute
508. Fung H, Shepard JD, Naiman SC, et al: Acute monocytic leukemia: A single institution myeloid leukemia and myelodysplastic syndrome in children with Down’s syndrome.
experience. Leuk Lymphoma 19:259, 1995. Leukemia 14:786, 2000.
509. Cuttner J, Conjalka MS, Reilly M, et al: Association of monocyte leukemia in patients 541. Athale UH, Razzouk BI, Raimondi SC, et al: Biology and outcome of childhood acute
with extreme leukocytosis. Am J Med 69:555, 1980. megakaryoblastic leukemia: A single institution’s experience. Blood 97:3727, 2001.
510. Jourdan E, Dombret H, Glaisner S, et al: Unexpected high incidence of intracranial 542. Yamada S, Hongo T, Okada S, et al: Distinctive multidrug sensitivity and outcome
subdural haematoma during intensive chemotherapy for acute myeloid leukaemia of acute erythroblastic and megakaryoblastic leukemia in children with Down syn-
with a monoblastic component. Br J Haematol 89:527, 1995. drome. Int J Hematol 74:428, 2001.
511. Scott CS, Stark AN, Limbert HJ, et al: Diagnostic and prognostic factors in acute 543. Tallman MS, Neuberg D, Bennett JM, et al: Acute megakaryocytic leukemia: The East-
monocytic leukemia: An analysis of 51 cases. Br J Haematol 69:247, 1988. ern Cooperative Group experience. Blood 96:2405, 2000.
512. Scherrer A, Kruithof EK, Grob JP: Plasminogen activator inhibitor-2 in patients with 544. Pagano L, Pulsoni A, Vignetti M, et al: Acute megakaryoblastic leukemia: Experience
monocytic leukemia. Leukemia 5:479, 1991. of GIMEMA trial. Leukemia 16:1622, 2002.
513. van Furth R, van Zwet TL: Cytochemical, functional, and proliferative characteris- 545. Stillman RG: A case of myeloid leukemia with predominance of eosinophilic cells.
tics of promonocytes and monocytes from patients with monocytic leukemia. Blood Med Rec 81:594, 1912.
62:298, 1983. 546. Harrington DS, Peterson C, Ness M, et al: Acute myelogenous leukemia with eosino-
514. van Furth R, Leijh PCJ, van Zwet TL, van den Barselaar MT: Phagocytic and intra- philic differentiation. Am J Clin Pathol 90:464, 1988.
cellular killing by peripheral blood monocytes of patients with monocytic leukemia. 547. Kueck BD, Smith RE, Parkin J, et al: Eosinophilic leukemia: A myeloproliferative dis-
Blood 59:1234, 1982. order distinct from the hypereosinophilic syndrome. Hematol Pathol 5:195, 1991.
515. Diaz MO, LeBeau MM, Pitha P, Rowley JD: Interferon and c-est-1 genes in the translo- 548. Sanada I, Asou N, Kajima S, et al: Acute myelogenous leukemia (FABM1) associated
cation (9;11)(p22;q23) in human acute monocytic leukemia. Science 231:265, 1986. with t(5;16) and eosinophilia. Cancer Genet Cytogenet 43:139, 1989.
516. Mavilo F, Testa U, Sposi NM, et al: Selective expression of fos protooncogene in human 549. Lichtman MA, Segel GB: Uncommon phenotypes of acute myelogenous leukemia:
acute myelomonocytic and monocytic leukemias: A molecular marker of terminal Basophilic, mast cell, eosinophilic, and myeloid dendritic cell subtypes: A review. Blood
differentiation. Blood 69:160, 1987. Cells Mol Dis 35:370, 2005.
517. Pinto A, Colletta G, DeVecchio L, et al: C-fos oncogene expression in human hemo- 550. Gabbas AG, Li CF: Acute non-lymphocytic leukemia with eosinophilic differentia-
poietic malignancies is restricted to acute leukemias with monocytic phenotype and tion. Am J Hematol 21:29, 1986.
to subsets of B cell leukemias. Blood 70:1450, 1987. 551. Brito-Babapulle F: Clonal eosinophilic disorders and the hypereosinophilic
518. Weide R, Parviz B, Pflüger K-H, Haveman K: Altered expression of the human retin- syndrome. Blood Rev 11:129, 1997.
oblastoma gene in monocytic leukaemias. Br J Haematol 83:428, 1993. 552. Menssen HD, Renkl H-J, Rieder H, et al: Distinction of eosinophilic leukaemia from
519. Cuttner J, Seremetis S, Najfield V, et al: TdT-positive acute leukemia with monocytoid idiopathic hypereosinophilic syndrome by analysis of Wilms tumor gene expression.
characteristics: Clinical, cytochemical, cytogenetic, and immunologic findings. Blood Br J Haematol 101:325, 1998.
64:237, 1984. 553. Joachim G: Über mastzellenleukämien. Dtsch Arch Klin Med 87:437, 1906.
520. Sun T, Wu E: Acute monoblastic leukemia with t(8;16): A distinct clinicopathologic 554. Goh KO, Anderson FW: Cytogenetic studies in basophilic chronic myelocytic leuke-
entity. Am J Hematol 66:207, 2001. mia. Arch Pathol Lab Med 193:288, 1979.

Kaushansky_chapter 88_p1373-1436.indd 1423 9/21/15 11:02 AM